Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study


SAVLI H. , Galimberti S., Sunnetci D. , Canestraro M., Palumbo G., Nagy B., ...Daha Fazla

TURKISH JOURNAL OF HEMATOLOGY, cilt.32, ss.206-212, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 32 Konu: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.4274/tjh.2014.0058
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Sayfa Sayıları: ss.206-212

Özet

Objective: We aimed to understand the molecular pathways affected by bortezomib and arsenic trioxide treatment on myelomonocytoid cell line P39.